We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Toshiba's CT System Ranked No. 1 Among Technology Vendors

By MedImaging staff writers
Posted on 14 Mar 2006
Toshiba America Medical Systems, Inc. More...
(TAMS; Tustin CA, USA) announced results of the KLAS (Orem, UT, USA) 64-slice computed tomography (CT) perception report, which ranked Toshiba's Aquilion 64-slice CT system, at the top in overall vendor ratings, outpacing leading diagnostic imaging manufacturers.

The KLAS 64-slice CT perception report surveyed more than 300 healthcare professionals, including imaging directors and managers, C-level executives, and physicians on survey categories, including service; ability to deliver product; upgrade path; scanner reliability; end-user presentation; cost and value; technology and architecture; postprocessing capabilities; and PACS (picture archiving and communication systems) integration. In addition to Toshiba's top distinction in overall vendor ratings, the survey showed that Toshiba scored highest in four categories, including cost and value, technology and architecture, postprocessing capabilities, and integration into existing PACS.

In addition to four first-place ratings, Toshiba's 64-slice CT system also tied for first place or scored above average in two more categories, including the ability to deliver product and the technology's upgrade path. Additionally, MD Buyline results released in January 2006 placed Toshiba first in the multislice CT category among four major medical imaging technology vendors with an average rating of nearly 9.5, on a scale of 10, based on performance, reliability, applications training, and service repair quality. Toshiba has held the top position with MD Buyline for more than three years.

The Aquilion 64 CFX allows clinicians to easily capture precise, motion-free images of the heart and coronary arteries to identify soft plaque or measure coronary blockage and detect signs of disease at its earliest stages, reducing the need for high-risk interventional procedures.



Related Links:
Toshiba America Medical Systems
KLAS

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.